Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1437-1444

  Kimani, Joshua ^b   Maclean, Ian W ^b   Bwayo, Job J ^b   MacDonald, Kelly ^b   Oyugi, Julius ^b   Maitha, Gregory M ^b   Peeling, Rosanna W ^b   Cheang, Mary ^b   Nagelkerke, Nicolaas J D ^b   Plummer, Francis A ^b   Brunham, Robert C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HEAT SHOCK PROTEIN; HLA A3 ANTIGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROSTITUTION; REINFECTION; RISK FACTOR; UTERINE CERVICITIS;

EID: 19244363174     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1437     Document Type: Article

References (23)

1. Washington AE, Aral SO, Wolner-Hanssen P, Grimes DA, Holmes KK. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991;266:2581-6.
2. Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease: what are the questions? JAMA 1991;266:2587-93.
3. Stephens RS. Challenge of Chlamydia research. Infect Agents Dis 1992; 1:279-93.
4. Morrison RP, Manning DS, Caldwell HD. Immunology of Chlamydia trachomatis infections: immunoprotective and immunopathogenetic responses. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms: sexually transmitted diseases. New York: Raven Press, 1992: 57-84.
5. Moller BR, Westrom L, Ahrons S, et al. Chlamydia trachomatis infection of the fallopian tubes: histological findings in two patients. Br J Vener Dis 1979;55:422-8.
6. El-asrar AMA, van den Oord JJ, Geboes K, Missotten L, Emarah MH, Desmet A. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 1989; 73:276-82.
7. Brunham RC, Peeling R. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994;3:218-33.
8. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990;263:54-9.
9. Brunham R, Yang C, Maclean I, Kimani K, Maitha G, Plummer F. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (ompl) gene. J Clin Invest 1994;94:458-63.
10. Kreiss JK, Koech D, Plummer FA, et al. AIDS virus infection in Nairobi prostitutes: spread of the epidemic to East Africa. N Engl J Med 1986; 314:414-8.
11. Wang SP, Kuo CC, Grayston JT. A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun 1973;7:356-60.
12. Toye B, Laferriere C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis 1993; 168:1236-40.
13. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease: a comprehensive analysis and considerations for developing a new model. JAMA 1991;266:2594-604.
14. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986; 104:187-93.
15. SAS Institute. SAS user's guide (statistics version). 5th ed. Cary, NC: SAS Institute, 1985.
16. Arno JN, Ricker VA, Batteiger BE, Katz DP, Gaine VA, Jones RB. Interferon-γ in endocervical secretions of women infected with Chlamydia trachomatis. J Infect Dis 1990;162:1385-9.
17. Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983;39:1491-4.
18. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76: 287-99.
19. Hermann E, Yu DTY, Meyer zum Büschenfelde KH, Fleischer B. HLAB27-restricted CDS T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993;342: 646-50.
20. + T lymphocyte-mediated lysis of Chlamydia infected epithelial cells utilizing an endogenous antigen pathway. J Immunol 1994;153:4588-95.
21. Starnbach MN, Bevan MJ, Lampe MF. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 1994;153;5183-9.
22. Daser A, Urlaub H, Henklein P. HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules. Mol Immunol 1994;31:331-6.
23. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985;227:257-61.